Patients' perceptions compared with objective ratings of asthma severity

Annals of Allergy, Asthma and Immunology

Volumn 77, Issue 3, 1996, Pages 209-215

  Nguyen, Bich Phuong ^c   Wilson, Sandra R ^b   German, Donald F ^a  

^a KAISER PERMANENTE MEDICAL CENTER   (United States)

^b AMERICAN INSTITUTES FOR RESEARCH   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIASTHMATIC AGENT;

ADULT; ARTICLE; ASTHMA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; FUNCTIONAL DISEASE; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT EDUCATION; PEAK EXPIRATORY FLOW; PRACTICE GUIDELINE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; SELF EVALUATION; SPIROMETRY;

EID: 0029742989     PISSN: 10811206     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1081-1206(10)63257-7     Document Type: Article

References (28)

1. Weiss KB, Gergen PJ, Wagener DK. Breathing better or wheezing worse? The changing epidemiology of asthma morbidity and mortality. Annu Rev Public Health 1993;14:491-513.
2. Evans R III, Mullally DI, Wilson RW, et al. National trends in the morbidity and mortality of asthma in the US: prevalence, hospitalization and death from asthma over two decades, 1965-1984. Chest 1987;91(6 Suppl): 65S-74S.
3. Sly RM. Mortality from asthma, 1974-1984. J Allergy Clin Immunol 1988;82:705-17.
4. Asthma - United States, 1980-1987. MMWR Morb Mortal Wkly Rep 1990; 39:493-7.
5. Sears MR. Increasing asthma mortality - fact or artifact? J Allergy Clin Immunol 1988;82:957-60.
6. Ruffin RE, Latimer KM, Schembri DA. Longitudinal study of near fatal asthma. Chest 1991;99:77-83.
7. Janson-Bjerklie S, Ferketich S, Benner P, Becker G. Clinical markers of asthma severity and risk: importance of subjective as well as objective factors. Heart Lung 1992;21:265-72.
8. Boulet LP, Deschesnes F, Turcotte H, Gignac F. Near-fatal asthma: clinical and physiologic features, perception of bronchoconstriction and psychologic profile. J Allergy Clin Immunol 1991; 88:838-46.
9. Burdon JGW, Juniper EF, Killian KJ, et al. The perception of breathlessness in asthma. Am Rev Respir Dis 1982; 126:825-8.
10. Turcotte H, Corbeil F, Boulet LP. Perception of breathlessness during bronchoconstriction induced by antigen, exercise, and histamine challenges. Thorax 1990;45:914-8.
11. Côté J, Leblanc P, Boulet LP. Perception of bronchoconstriction in normal and asthmatic subjects [Abstract]. Am Rev Respir Dis 1987;135:A321.
12. Burki NK, Mitchell K, Chaudhary BA, Zechman FW. The ability of asthmatics to detect added resistive loads. Am Rev Respir Dis 1978;117:71-5.
13. Rubinfeld AR, Pain MCF. Perception of asthma. Lancet 1976;24:882-4.
14. Rubinfeld AR, Pain MCF. Conscious perception of bronchospasm as a protective phenomena in asthma. Chest 1977;72:154-8.
15. McFadden ER Jr, Kiser R, DeGroot WJ. Acute bronchial asthma: relations between clinical and physiologic manifestations. N Engl J Med 1973;288: 221-5.
16. National Heart, Lung, and Blood Institute. Guidelines for the diagnosis and management of asthma (National Asthma Education Program Expert Panel Report) Bethesda: National Institutes of Health, 1991. (DHHS Publ. No 91-3042).
17. American Thoracic Society. Evaluation of impairment/disability secondary to respiratory disorders. Am Rev Respir Dis 1986;34:1205-9.
18. Wilson SR, Scamagas P, German DF, et al. A controlled trial of two forms of self-management education for adults with asthma. Am J Med 1993;94: 564-76.
19. Nunn AJ, Gregg I. New regression equations for predicting peak expiratory flow in adults. Br Med J 1989; 298:1068-70.
20. Bagg LR, Hughes DTD. Diurnal variation in peak expiratory flow in asthmatics. Eur J Respir Dis 1980;61: 298-302.
21. American Thoracic Society. Medical Section of the American Lung Association. Guidelines for the evaluation of impairment/disability in patients with asthma. Am Rev Respir Dis 1993;147: 1056-61.
22. Li D, German D, Lulla S, et al. Prospective study of hospitalization for asthma: a preliminary risk factor model. Am J Respir Crit Care Med 1995;151:647-55.
23. Kimmel SR. Use of the peak flow meter in office practice. Am Fam Physician 1986 Dec;34(6):107-11.
24. Turner-Warwick M. Epidemiology of nocturnal asthma. Am J Med 1988; 85(1B):6-8.
25. Saetta M, Thiene G, Crescioli S, Fabbri LM. Fatal asthma in a young patient with severe bronchial hyperresponsiveness but stable peak flow records. Eur Respir J 1989;2:1008-12.
26. Boner AL, De Stefane G, Piacentini GL, et al. Perception of bronchoconstriction in chronic asthma. J Asthma 1992;29:323-30.
27. König P, Rejent A. Subjective and objective means of assessing cystic fibrosis and asthma. Ann Allergy 1982;49: 86-92.
28. Perception of breathlessness in asthma [Editorial]. Lancet 1983;1:912-13.